Plain-English translation of NCT06139042 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The LIBRARY study is testing whether a new blood test can catch liver, bile duct, and pancreatic cancers very early—before they cause symptoms. The test looks for tiny pieces of cancer DNA, certain proteins, and microRNA (small genetic molecules) in your blood. Researchers hope this simple blood draw could help doctors find these cancers at a stage when treatment works best.
These three cancers are often found too late, when they're harder to treat. The researchers want to know if this blood test can spot them much earlier, giving patients a better chance of survival and more treatment options.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll visit a hospital or clinic and have blood drawn—similar to a routine blood test. Depending on which group you're in (cancer patients, people with benign liver conditions, or healthy volunteers), you may have just one visit or possibly a few follow-up visits to give additional samples. The researchers will use your blood to run their new cancer detection test and compare results across the three groups.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators
Guangzhou Burning Rock Dx Co., Ltd.
Enrollment target
~1,608 participants
Started
November 2023
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years – 75 Years
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yuan Ding, Phd
Second Affiliated Hospital, School of Medicine, Zhejiang University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.